On September 20th, Chia Tai Ophthalmology-B (6622.HK) opened at a high of 5.19% and reported HK$1.42. In terms of news, the company announced that its research and development of the anti-glaucoma drug Beminitan prostaglandin eye drops (Cinzin) has been approved by the National Medical Products Administration for listing. The company stated that the Beminitan prostaglandin eye drops is the first single-dose Beminitan prostaglandin eye drops in China without preservatives, and is used to reduce intraocular pressure in patients with angle-closure glaucoma and ocular hypertension.
港股异动丨兆科眼科高开超5%，抗青光眼药物晶贝清获国家药监局批准上市
HK stocks surged, Shares of Mega Vision Group rose more than 5%, and the antiglaucoma drug Jingbeiqing was approved by the National Medical Products Administration for listing.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Investment Course
Choose stocks based on financial reports
Quickly master financial season learning guidelines
When the financial season comes, company stock prices are the most likely to rise and fall, and many excellent investors will see the financial season as a good
How to view Tesla's performance in January 2025? Pay attention to these four key points.
It's earnings season for US stocks again. The performance of giant companies not only affects their own stock prices but also influences the overall trend of th
In 【2024.11】, surged more than 0.04 million times, achieving the title of stock god Buffett! How do you view Berkshire's performance?
When it comes to legendary figures in the investment world, the name of Warren Buffett, the helm of Berkshire Hathaway, is definitely unavoidable. $Berkshire Ha